Roche to launch global study of Elevidys following EU rejection Clinical Trials Arena 15:11 Fri, 17 Apr
Roche launches global Phase III Elevidys trial to support EU approval for Duchenne gene therapy Manufacturing Chemist 12:27 Fri, 17 Apr
Will Roche’s New Global Elevidys Phase 3 Trial Shift Sarepta Therapeutics' (SRPT) Gene Therapy Narrative? Simply Wall St 06:48 Fri, 17 Apr
Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy FiercePharma 15:12 Thu, 16 Apr
STAT Plus: Roche to launch another Elevidys trial, with eyes on European approval STAT 11:39 Thu, 16 Apr